Recent publications described many discrepant findings about thyroid “stunning” after the
administration of 131I diagnostic activities to patients with differentiated thyroid carcinoma …

When thyroid tissues exhibited concentrations of therapeutic 131I that appeared to be less
than that predicted by data from the preceding diagnostic 131I, the phenomenon was called …

Aim To review published in-vivo and in-vitro quantitative dosimetric studies on thyroid
stunning in order to derive novel data applicable in clinical practice. Methods A non-linear …

The aim of this study was to investigate the influence of the diagnostic administration of 74
MBq 131I on subsequent uptake of therapeutic radioiodine in thyroid cancer patients …

We performed a prospective random study to assess possible thyroid stunning by a 185-
MBq iodine-131 dose used to diagnose thyroid remnants. Patients with differentiated thyroid …

The aims of this study were to evaluate the efficacy of an empirically determined 'fixed'high
ablative dose of radioiodine (131 I) therapy and to determine the utility of ultrasonography …

The use of 131I in doses of several mCi for scans can stun the thyrocytes and thyroid cancer
cells, whereas the usual dose (300 μCi) of 123I does not. We compared the diagnostic …

Radio-iodine therapy for thyroid carcinoma has been given for many years but its use
remains surrounded with controversies. Should patients routinely have thyroid remnants …

Detection of residual tissue after thyroidectomy for papillary or follicular thyroid carcinoma
may be performed using diagnostic imaging with either 123I or 131I. The former is often …

MATERIALS AND METHODS Twelve consecutivepatients with focal neck uptake after a
dosimetric study were re-evaluatedafter subsequentradioiodine treatment. The 24-h (in one …